Skip to main content
. 2023 Jan 25;4(2):100916. doi: 10.1016/j.xcrm.2023.100916

Table 4.

Key efficacy outcomes for the overall and PD-L1 CPS ≥5 population

Overall PD-L1 CPS ≥5
1. ORR 30% (16.63%, 46.51%), (9/30) 41.67% (18.1%, 68.48%), (5/12)
2. Disease control rate 83.33% (68.1%, 93.19%), (25/30) 91.67% (66.13%, 99.57%), (11/12)
3. Median PFS (months) 4.5 (3.7, 6.2) 6.1 (3.7, not estimable)
4. Median OS (months) 8.7 (7.2, 19.7) 14.4 (6.1, not estimable)
5. 6-month PFS rate 36.67% (22.11%, 53.31%), (11/30) 50% (24.53%, 75.47%), (6/12)